{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:49:51Z","timestamp":1767962991887,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartfailure.theclinics.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.hfc.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T06:46:59Z","timestamp":1467182819000},"page":"349-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cardiohepatic Interactions"],"prefix":"10.1016","volume":"12","author":[{"given":"Akshay","family":"Pendyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Gelow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.hfc.2016.03.011_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cardfail.2015.04.013","article-title":"Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee","volume":"21","author":"Fang","year":"2015","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hfc.2016.03.011_bib2","series-title":"Hepatology: clinical cases uncovered","author":"Nash","year":"2011"},{"issue":"12","key":"10.1016\/j.hfc.2016.03.011_bib3","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.amjmed.2015.07.033","article-title":"The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis","volume":"128","author":"Tapper","year":"2015","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.hfc.2016.03.011_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1067\/mhj.2000.107177","article-title":"Heart diseases affecting the liver and liver diseases affecting the heart","volume":"140","author":"Naschitz","year":"2000","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib5","first-page":"159","article-title":"Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy","volume":"104","author":"Arcidi","year":"1981","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.hfc.2016.03.011_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.md.0000101573.54295.bd","article-title":"Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases","volume":"82","author":"Henrion","year":"2003","journal-title":"Medicine"},{"issue":"24","key":"10.1016\/j.hfc.2016.03.011_bib7","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","article-title":"Cardiohepatic interactions in heart failure: an overview and clinical implications","volume":"61","author":"Samsky","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","article-title":"Oxidative stress-related molecules and liver fibrosis","volume":"35","author":"Parola","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.hfc.2016.03.011_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1478-3231.2006.01339.x","article-title":"How to modulate inflammatory cytokines in liver diseases","volume":"26","author":"Tilg","year":"2006","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.hfc.2016.03.011_bib10","first-page":"1232","article-title":"Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis)","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.hfc.2016.03.011_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.healun.2015.04.002","article-title":"Assessing the liver to predict outcomes in heart transplantation","volume":"34","author":"Givertz","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.hfc.2016.03.011_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCHEARTFAILURE.109.872556","article-title":"Clinical predictors of hepatic fibrosis in chronic advanced heart failure","volume":"3","author":"Gelow","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/jhep.2003.50062","article-title":"Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations","volume":"37","author":"Myers","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.hfc.2016.03.011_bib14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","article-title":"Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial","volume":"14","author":"Ambrosy","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.hfc.2016.03.011_bib15","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","article-title":"Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure","volume":"34","author":"Nikolaou","year":"2013","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.hfc.2016.03.011_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cardfail.2014.05.001","article-title":"Longitudinal trends, hemodynamic profiles, and prognostic value of abnormal liver function tests in patients with acute decompensated heart failure: an analysis of the ESCAPE trial","volume":"20","author":"Scholfield","year":"2014","journal-title":"J\u00a0Card Fail"},{"issue":"6","key":"10.1016\/j.hfc.2016.03.011_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cardfail.2014.03.003","article-title":"Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure\u2014results from the relaxin for the treatment of patients with acute heart failure study","volume":"20","author":"van Deursen","year":"2014","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hfc.2016.03.011_bib18","article-title":"Liver\u00a0function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF","author":"Samsky","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.hfc.2016.03.011_bib19","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9149(02)02886-2","article-title":"Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation","volume":"90","author":"Lau","year":"2002","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2016.03.011_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"van Deursen","year":"2010","journal-title":"J\u00a0Card Fail"},{"issue":"1","key":"10.1016\/j.hfc.2016.03.011_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2008.10.016","article-title":"Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?","volume":"50","author":"Bonekamp","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2007.05.001","article-title":"Transjugular liver biopsy\u2013indications, adequacy, quality of specimens, and complications\u2013a systematic review","volume":"47","author":"Kalambokis","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.hfc.2016.03.011_bib24","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/modpathol.2014.79","article-title":"Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity","volume":"27","author":"Dai","year":"2014","journal-title":"Mod Pathol"},{"issue":"22","key":"10.1016\/j.hfc.2016.03.011_bib25","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2012.12.056","article-title":"Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction","volume":"61","author":"Kim","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2016.03.011_bib26","doi-asserted-by":"crossref","first-page":"e100618","DOI":"10.1371\/journal.pone.0100618","article-title":"Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure","volume":"9","author":"Abe","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.hfc.2016.03.011_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tim.2003.12.005","article-title":"Pathophysiology of hepatitis C virus infection and related liver disease","volume":"12","author":"Pawlotsky","year":"2004","journal-title":"Trends Microbiol"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.22992","article-title":"Outcomes of a patient-to-patient outbreak of genotype 3a hepatitis C","volume":"50","author":"Mailliard","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/599371","article-title":"Hepatitis C virus infection and the risk of coronary disease","volume":"49","author":"Butt","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/jiv396","article-title":"A\u00a0cross-sectional study of the association between chronic hepatitis C virus infection and subclinical coronary atherosclerosis among participants in the multicenter AIDS Cohort Study","volume":"213","author":"McKibben","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.hfc.2016.03.011_bib32","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/01.CIR.92.9.2519","article-title":"Dilated cardiomyopathy associated with hepatitis C virus infection","volume":"92","author":"Matsumori","year":"1995","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2016.03.011_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardfail.2005.11.004","article-title":"Myocarditis and heart failure associated with hepatitis C virus infection","volume":"12","author":"Matsumori","year":"2006","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.hfc.2016.03.011_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1378\/chest.99.3.557","article-title":"Cardiotoxicity of interferon. A review of 44 cases","volume":"99","author":"Sonnenblick","year":"1991","journal-title":"Chest"},{"issue":"20","key":"10.1016\/j.hfc.2016.03.011_bib35","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.hfc.2016.03.011_bib36","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","article-title":"Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis","volume":"370","author":"Kowdley","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2016.03.011_bib37","unstructured":"FDA. FDA drug safety communication: FDA warns of serious slowing of the heart rate when antiarrhythmic drug amiodarone is used with hepatitis C treatments containing sofosbuvir (Harvoni) or Sovaldi in combination with another direct acting antiviral drug. 2015. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm439484.htm. Accessed January 11, 2016."},{"issue":"1","key":"10.1016\/j.hfc.2016.03.011_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhep.2015.01.026","article-title":"Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir\/ritonavir, ombitasvir, and dasabuvir","volume":"63","author":"Menon","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCULATIONAHA.108.838656","article-title":"Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality","volume":"121","author":"Matthews","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2016.03.011_bib40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.healun.2012.02.027","article-title":"Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system","volume":"31","author":"Yang","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.hfc.2016.03.011_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10047-015-0853-x","article-title":"Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices","volume":"19","author":"Yost","year":"2016","journal-title":"J\u00a0Artif Organs"},{"issue":"10","key":"10.1016\/j.hfc.2016.03.011_bib42","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.amjcard.2015.08.022","article-title":"Comparison of outcome in patients with versus without ascites referred for either cardiac transplantation or ventricular assist device placement","volume":"116","author":"Kim","year":"2015","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2016.03.011_bib43","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-5223(98)70171-0","article-title":"Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation","volume":"116","author":"Reinhartz","year":"1998","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.hfc.2016.03.011_bib44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jocs.12318","article-title":"HeartMate II left ventricular assist device implantation in\u00a0patients with advanced hepatic dysfunction","volume":"29","author":"Demirozu","year":"2014","journal-title":"J\u00a0Card Surg"},{"issue":"1","key":"10.1016\/j.hfc.2016.03.011_bib45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jtcvs.2015.08.073","article-title":"Periportal fibrosis without cirrhosis does not affect outcomes after continuous flow ventricular assist device implantation","volume":"151","author":"Sargent","year":"2016","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"7","key":"10.1016\/j.hfc.2016.03.011_bib46","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.healun.2014.12.009","article-title":"Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction","volume":"34","author":"Farr","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.hfc.2016.03.011_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ejcts.2007.05.015","article-title":"Heart transplantation in patients with extreme right ventricular failure","volume":"32","author":"Hsu","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejcts.2008.05.003","article-title":"Heart transplantation in patients with liver cirrhosis","volume":"34","author":"Hsu","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"10.1016\/j.hfc.2016.03.011_bib49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.healun.2012.02.008","article-title":"Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction","volume":"31","author":"Chokshi","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.healun.2015.10.008","article-title":"Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: evidence from the registry of the United Network for Organ Sharing","volume":"35","author":"Deo","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.hfc.2016.03.011_bib51","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/modpathol.2015.40","article-title":"The liver in heart failure: a biopsy and explant series of the histopathologic and laboratory findings with a particular focus on pre-cardiac transplant evaluation","volume":"28","author":"Louie","year":"2015","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.hfc.2016.03.011_bib52","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1432-2277.2012.01551.x","article-title":"A\u00a0review of the United States experience with combined heart-liver transplantation","volume":"25","author":"Cannon","year":"2012","journal-title":"Transpl Int"},{"issue":"5","key":"10.1016\/j.hfc.2016.03.011_bib53","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/SLA.0b013e31817fc2b8","article-title":"The combined organ effect: protection against rejection?","volume":"248","author":"Rana","year":"2008","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/ctr.12053","article-title":"Long-term outcome in patients treated with combined heart and liver transplantation for familial amyloidotic cardiomyopathy","volume":"27","author":"Nelson","year":"2013","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.hfc.2016.03.011_bib55","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/TP.0b013e31829c24a6","article-title":"Hepatitis C virus infection in heart transplantation: is ventricular assist device therapy an option?","volume":"96","author":"Rajagopalan","year":"2013","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.hfc.2016.03.011_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchf.2013.10.008","article-title":"Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device","volume":"2","author":"Meyer","year":"2014","journal-title":"JACC Heart Failure"},{"issue":"6","key":"10.1016\/j.hfc.2016.03.011_bib57","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MAT.0b013e3182a53d00","article-title":"High rates of false-positive hepatitis C antibody tests can occur after left ventricular assist device implantation","volume":"59","author":"Srivastava","year":"2013","journal-title":"ASAIO J"},{"issue":"15","key":"10.1016\/j.hfc.2016.03.011_bib58","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/jama.296.15.1843","article-title":"Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients","volume":"296","author":"Gasink","year":"2006","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.hfc.2016.03.011_bib59","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/j.transproceed.2008.08.108","article-title":"Hepatitis C virus infection after renal transplantation","volume":"40","author":"Romero","year":"2008","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.hfc.2016.03.011_bib60","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0041-1345(03)00717-6","article-title":"Outcome of kidney transplant in chronic hepatitis C virus patients: effect of pretransplantation interferon-alpha2b monotherapy","volume":"35","author":"Gonz\u00e1lez-Roncero","year":"2003","journal-title":"Transplant Proc"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2016.03.011_bib61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1478-3231.2010.02396.x","article-title":"The difficulties of managing severe hepatitis B virus reactivation","volume":"31","author":"Roche","year":"2011","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.hfc.2016.03.011_bib62","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/TP.0b013e3181bd3e59","article-title":"Impact of hepatitis C infection on outcomes after heart transplantation","volume":"88","author":"Fong","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.hfc.2016.03.011_bib63","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.healun.2011.06.003","article-title":"Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity.","volume":"30","author":"Lee","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.hfc.2016.03.011_bib64","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.510300519","article-title":"Outcome of de novo hepatitis C virus infection in heart transplant recipients","volume":"30","author":"Ong","year":"1999","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.hfc.2016.03.011_bib65","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1053-2498(00)00062-0","article-title":"Hepatitis C transmission and infection by orthotopic heart transplantation","volume":"19","author":"Pfau","year":"2000","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.hfc.2016.03.011_bib66","first-page":"865","article-title":"Prevalence and outcome of hepatitis C infection among heart transplant recipients","volume":"14","author":"Zein","year":"1995","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.hfc.2016.03.011_bib67","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/gast.2000.17951","article-title":"Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival","volume":"119","author":"Lunel","year":"2000","journal-title":"Gastroenterology"},{"issue":"Rr-8","key":"10.1016\/j.hfc.2016.03.011_bib68","first-page":"1","article-title":"Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention","volume":"43","year":"1994","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.hfc.2016.03.011_bib69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/003335491312800403","article-title":"PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation","volume":"128","author":"Seem","year":"2013","journal-title":"Public Health Rep"},{"issue":"1","key":"10.1016\/j.hfc.2016.03.011_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"8","key":"10.1016\/j.hfc.2016.03.011_bib71","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1155\/2011\/947838","article-title":"A\u00a0concise review of hepatitis C in heart and lung transplantation","volume":"25","author":"Kim","year":"2011","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"10.1016\/j.hfc.2016.03.011_bib72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL Recommendations on Treatment of Hepatitis C 2015","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hfc.2016.03.011_bib73","unstructured":"AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C. 2015. Available at: http:\/\/www.hcvguidelines.org. Accessed January 14, 2016."},{"issue":"5","key":"10.1016\/j.hfc.2016.03.011_bib74","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hep.25831","article-title":"Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers","volume":"56","author":"Hulskotte","year":"2012","journal-title":"Hepatology"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713616300307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713616300307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T21:55:57Z","timestamp":1536616557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713616300307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1551713616300307"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2016.03.011","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiohepatic Interactions","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2016.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}